Vivani Medical Arranges $5.1 Million for Semaglutide Implant
Vivani Medical expects $5.1 million in gross proceeds from a 5,049,506-share placement, with two directors buying at $1.01 ahead of a planned 2027 Phase 2 study.
Topic
Topic
Vivani Medical expects $5.1 million in gross proceeds from a 5,049,506-share placement, with two directors buying at $1.01 ahead of a planned 2027 Phase 2 study.